Skip to main content
Log in

Effect of a glucan, sizofiran, on natural-killer activity of 5-fluorouracil-treated murine bone marrow cells

  • Original articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

The number of bone marrow cells in C3H/He mice was reduced 3–4 days after treatment with 130 mg/kg intraperitoneal 5-fluorouracil (5-FU). Higher rates of spontaneous proliferation and natural killer (NK) activity, accompanied by an increase in asialoGM1-positive cells, were observed in treated mice. When sizofiran at a dose of 200 µg/animal was intramuscularly injected after 5-FU treatment, the rates of proliferation and NK activity of bone marrow cells were higher than with 5-FU alone. The cell number was not influenced by sizofiran alone. These results indicate that all precursors of the various mature cell types (including NK cells) differentiate and regenerate rapidly to replace cells damaged by 5-FU treatment, and that sizofiran has the potential to assist this recovery. These results suggest that administration of sizofiran after chemotherapy may be useful in cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cohen SA, Tsung S, Doerr RJ, Goldrosen MH (1990) Role of asialo-GM1 positive liver cells from athymic nude or polyinosinic-polycytidylic acid-treated mice in suppressing colon-derived experimental hepatic metastasis. Cancer Res 50: 18 342

    Google Scholar 

  2. Hansson M, Kiessling R, Anderson B (1981) Human fetal thymus and bone marrow contain target cells for natural killer cells. Eur J Immunol 11: 84

    Google Scholar 

  3. Hansson M, Beran M, Anderson B, Kiessling R (1982) Inhibition of in vitro granulopoiesis by autologous allogeneic human NK cells. J Immunol 129: 126

    PubMed  Google Scholar 

  4. Herberman RB, Ortaldo JR (1981) Natural killer cells: their role in defenses against diseases. Science 214: 24

    PubMed  Google Scholar 

  5. Ho MK, Springer TA (1982) Mac-2, a novel 32,000M r mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies. J Immunol 128: 1221

    PubMed  Google Scholar 

  6. Kalland T (1990) Regeneration of natural killer progenitors. Studies with a novel immunomodulator with distinct effects at the precursor level. J Immunol 144: 4472

    PubMed  Google Scholar 

  7. Komatsu N, Okubo S, Kikumoto S, Kimura K, Saito S (1969) Host mediated antitumor action of schizophyllan, a glucan produced bySchizophillum commune. Jpn J Cancer Res (Gann) 60: 137

    Google Scholar 

  8. Marcel RMB, Boggs SS, Herberman RB, Hiserodt JC (1990) The generation of natural killer (NK) cells from NK precursor cells in rat long-term bone marrow cultures. J Exp Med 172: 303

    PubMed  Google Scholar 

  9. Mercurio AM, Schwarting GA, Robbins PW (1984) Glycolipids of the mouse peritoneal macrophage—alterations in amount and surface exposure of specific glycolipid species occur in response to inflammation and tumoricidal activation. J Exp Med 160: 1114

    PubMed  Google Scholar 

  10. Migliorati G, Cannarile L, Herberman RB, Bartocci A, Stanley ER, Riccardi C (1987) Role of interleukin 2 (IL-2) and hemopoietin-1 (H-1) in the generation of mouse natural killer (NK) cells from primitive bone marrow precursors. J Immunol 138: 3618

    PubMed  Google Scholar 

  11. Mitani M, Ariga T, Matsuo T, Asano T, Saito G (1980) Anti-tumor effect of schizophyllan, an an immunomodulator on syngeneic tumors. Int J Immunopharmacol 2: 174

    Google Scholar 

  12. Moor MAS, Stolfi RL, Martin DS (1990) Hematologic effects of interleukine-1b, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor in tumor-bearing mice treated with fluorouracil. J Natl Cancer Inst 82: 1031

    PubMed  Google Scholar 

  13. Nibbering PH, Van de Gevel JS, Van Furth R (1990) A cell-ELISA for the quantification of adherent murine macrophages and the surface expression of antigens. J Immunol Methods 131: 25

    PubMed  Google Scholar 

  14. Norisuye T, Yanaki T, Fujita H (1980) Triple helix of aSchizophyllum commune polysaccharide in aqueous solution. J Polym Sci: Physics Edit 18: 547

    Google Scholar 

  15. Sato M, Kaji R, Urata M, Yoshida H, Yanagawa T, Miyamoto K, Azuma M, Furumoto N, Saito M (1988) Monoclonal antibody to the streptococcal preparation OK-432: tissue OK-432 localization and analysis of interaction between OK-432 and macrophages or NK cells in human salivary adenocarcinoma-bearing nude mice given OK-432. J Biol Response Mod 7: 212

    PubMed  Google Scholar 

  16. Sugawara I, Lee KC, Wong M (1984) Schizophillan(SPG)-treated macrophages and anti-tumor activities against syngeneic and allogeneic tumor cells: I. Characteristics of SPG-treated macrophages. Cancer Immunol Immunother 16: 137

    PubMed  Google Scholar 

  17. Suzuki R, Handa K, Itoh K, Kumagai K (1983) Natural killer cells as a responder to interleukin 2 (IL-2): I. Proliferative response and establishment of cloned cells. J Immunol 130: 981

    PubMed  Google Scholar 

  18. Suzuki R, Suzuki S, Igarashi M, Kumagai K (1986) Induction of interleukin 3 but not interleukin 2 or interferon production in the syngeneic mixed reaction. J Immunol 137: 1564

    PubMed  Google Scholar 

  19. Talmadge JE, Meyers KM, Prieur DJ, Starkey JR (1980) Role of NK cells in tumor growth and metastasis inbeige mice. Nature 284: 622

    PubMed  Google Scholar 

  20. Tsuchiya Y, Igarashi M, Suzuki R, Kumagai K (1988) Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells. J Immunol 141: 699

    PubMed  Google Scholar 

  21. Tsuchiya Y, Igarashi M, Inoue M, Kumagai K (1989) Cytokine-related immunomodulating activities of an anti-tumor glucan, sizofiran (SPG). J PharmacobioDyn 12: 616

    PubMed  Google Scholar 

  22. Uchida A, Micksche M (1981) In vitro augmentation of natural killing activity by OK-432. Int J Immunopharmacol 3: 365

    PubMed  Google Scholar 

  23. Uchida A, Yagita M, Sugiyama H, Hoshino T, Moor M (1984) Strong natural killer (NK) cell activity in bone marrow of myeloma patients: accelerated maturation of bone marrow NK cells and their interaction with other bone marrow cells. Int J Cancer 34: 375

    PubMed  Google Scholar 

  24. Young JC, Mule JJ, Rosenberg SA (1986) Muline lymphokine activated killer (LAK) cells; phenotypic characterization of the rat longterm bone marrow cultures. J Exp Med 172: 303

    Google Scholar 

  25. Young LHY, Klavinskis LS, Oldstone MBA, Young JDE (1989) In vivo expression of perforin by CD8 positive lymphocytes during an acute viral infection. J Exp Med 169: 2159

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tsuchiya, Y., Matsutani, M., Inoue, M. et al. Effect of a glucan, sizofiran, on natural-killer activity of 5-fluorouracil-treated murine bone marrow cells. Cancer Immunol Immunother 34, 17–23 (1991). https://doi.org/10.1007/BF01741319

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01741319

Key words

Navigation